rss
J Neurol Neurosurg Psychiatry 75:1672-1677 doi:10.1136/jnnp.2003.028761
  • Paper

Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study

Table 3

 Pharmacokinetic parameters for l-dopa and 3-OMD with LD/CD, and 15 and 30 g mucuna

LD/CD (SEM) 15 g mucuna 30 g mucuna Difference LD/CD v 15 g mucuna (p value) Difference LD/CD v 30 g mucuna (p value)
AUC, area under the concentration v time curve; Cmax, peak plasma concentration; LD/CD, l-dopa/carbidopa; SEM, standard error of the mean; Tmax, time to peak plasma concentration; t½, apparent plasma elimination half life; 3-OMD, 3-O-methyl-dopa.
l-Dopa
    AUC (ng h/ml) 16 243 (2543) 16 306 (4024) 43 087 (9735) NS 0.012
    Cmax (ng/ml) 6956 (1098) 8608 (1979) 14 606 (2662) NS 0.025
    Tmax (min) 95.5 (10.5) 61.8 (12.9) 72.4 (15.1) 0.04 NS
    t½ (min) 90.8 (23.8) 58.6 (5.1) 94.0 (25.5) NS NS
3-OMD
    AUC (ng h/ml) 24 267 (4559) 20 292 (2833) 22 698 (2833) 0.05 NS

This Article

Latest from Practical Neurology

Latest from Practical Neurology

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

  • BMJ Careers - Latest Neurology and Neurosurgery jobs

    Latest neurology and neurosurgery jobs